Moderate-to-Severe Psoriasis
Showing 1 - 25 of >10,000
Moderate-to-Severe Plaque Psoriasis Trial in Shenyang (Jaktinib, Placebo)
Recruiting
- Moderate-to-Severe Plaque Psoriasis
- Jaktinib
- Placebo
-
Shenyang, Liaoning, ChinaThe First Affiliated Hospital of China Medical University
Nov 28, 2022
Psoriasis Trial in Gwangju (Routine practice groups, EARP group)
Recruiting
- Psoriasis
- Routine practice groups
- EARP group
-
Gwangju, Korea, Republic ofNovartis Investigative Site
Feb 24, 2023
Preferences of Japan With Moderate-to-Severe Psoriasis Using
Completed
- Psoriasis
-
Morrisville, North CarolinaLocal Institution
Jun 2, 2022
Sleep in Moderate-to-Severe Psoriasis
Recruiting
- Psoriasis Vulgaris
- Polysomnography (PSG)
-
San Francisco, CaliforniaUCSF Psorisis Center
Mar 24, 2022
Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis Trial (Placebo, Bimekizumab)
Not yet recruiting
- Chronic Plaque Psoriasis
- Moderate to Severe Chronic Plaque Psoriasis
- Placebo
- Bimekizumab
- (no location specified)
Aug 21, 2023
Genital Psoriasis, Scalp Psoriasis Trial (Risankizumab, Placebo for Risankizumab)
Not yet recruiting
- Genital Psoriasis
- Scalp Psoriasis
- Risankizumab
- Placebo for Risankizumab
- (no location specified)
Jul 24, 2023
Tolerability in Pediatric Patients With Psoriasis
Not yet recruiting
- Moderate-to-severe Plaque Psoriasis
- Secukinumab
- (no location specified)
Nov 16, 2023
Disease Symptoms in Adult Moderate to Severe Psoriasis Treated
Recruiting
- Psoriasis
-
Beer Sheva, HaDarom, Israel
- +7 more
Aug 3, 2022
Moderate-to-severe Plaque Psoriasis Patients Response to
Completed
- Moderate-to-severe Plaque Psoriasis
-
Jakarta, IndonesiaMangga Besar Clinic
Mar 15, 2023
Deucravacitinib in Moderate-to-Severe Plaque Psoriasis in
Recruiting
- Plaque Psoriasis
-
Selters, Rhineland-Palatinate, GermanyDermatologische Spezial- und Schwerpunktpraxis Selters
Oct 23, 2023
Validate Cumulative Life Course Impairment Instrument in Adult
Not yet recruiting
- Psoriasis
- (no location specified)
Jul 17, 2023
Psoriasis Trial in Shanghai (HS-10374 tablets 1mg, HS-10374 tablets 5mg, HS-10374-matched tablets)
Not yet recruiting
- Psoriasis
- HS-10374 tablets 1mg
- +2 more
-
Shanghai, Shanghai, ChinaHuashan Hospital of Fudan University
Oct 8, 2023
Plaque Psoriasis Trial in Karachi (Secukinumab Injection)
Completed
- Plaque Psoriasis
- Secukinumab Injection
-
Karachi, Sindh, PakistanJinnah Post graduate Medical centre
Jun 4, 2023
Psoriasis Trial in Bridgewater (Brodalumab, Comparator Drug (non-biologic IL-17 inhibitors))
Enrolling by invitation
- Psoriasis
- Brodalumab
- Comparator Drug (non-biologic IL-17 inhibitors)
-
Bridgewater, New JerseyRegistry
Dec 14, 2021
Moderate-to-severe Psoriasis in Adults: Update of French
Recruiting
- Psoriasis
- +10 more
- Experts consensus
-
Paris, FranceCenter of Evidence of Dermatology
Nov 21, 2021
Psoriasis Trial in Lahore (Apremilast 30mg)
Completed
- Psoriasis
- Apremilast 30mg
-
Lahore, Punjab, PakistanGhurki Hospital
Sep 5, 2023
